The treatment, known as Papillon, could allow patients with rectal cancer to avoid the need for a stoma
Notifications can be managed in browser preferences.
Swipe for next article
The treatment, known as Papillon, could allow patients with rectal cancer to avoid the need for a stoma
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
A pioneering low-energy X-ray treatment for a specific type of cancer has received approval for use within the NHS, potentially allowing patients to avoid invasive surgery.
The treatment, known as Papillon, has been recommended by the National Institute for Health and Care Excellence (Nice)
Bladder cancer is the ninth most common cancer in the world, the fourth most common cancer in men, and the 11th most common…
The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments
Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit
Researchers say the findings offer a promising way to improve existing cancer therapies as well as develop new ones
One early adopter describes how he was in remission ‘within the first two or three weeks’ after the treatment
